Clinical effectiveness of newer pulpotomy agents
- Conditions
- Health Condition 1: K040- Pulpitis
- Registration Number
- CTRI/2022/04/042044
- Lead Sponsor
- S B Divya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1)Patients with symptomatic Irreversible Pulpitis of age 18 to 40 years permanent mature molar teeth with symptomatic irreversible pulpitis
2)Both Maxillary and Mandibular molar teeth.
3) A clinical diagnosis consistent with irreversible pulpitis will be established in all cases based on a history of severe spontaneous lingering pain that could be reproduced by cold testing.
4)Teeth which are tender to percussion can be included but those with periapical lesions, resorption of root must be excluded.
1)Patients < 18years of age.
2)Patients of age > 40 years of age
3)Medically compromised patients
4)Pregnant and lactating women.
5)Patients undergoing fixed orthodontic therapy
6)Patients with facial deformity including cleft lip/palate.
7)Teeth with apical periodontitis.
8)Teeth with fracture or crack lines.
9)Teeth with abrasion on the same tooth.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Post operative pain , tenderness and swelling (yes or no) <br/ ><br>Pain will be assessed using Visual Analog Scale (VAS) <br/ ><br>Timepoint: Post operative pain will be assessed after 24 hours and 48 hours, tenderness and swelling (yes or no)will be checked after 48 hours and 3 months <br/ ><br>Pain will be assessed using Visual Analog Scale (VAS) <br/ ><br>
- Secondary Outcome Measures
Name Time Method Presence of periapical lesions at 3, 6 & 12 months recall. Dentin bridge formation at 12 months interval through CBCT radiographic analysis. <br/ ><br>Timepoint: 3,6,12 months